ArticleActa biomaterialia2022

An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension.

Elisabeth Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.